ARS Pharmaceuticals

About:

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Website: https://ars-pharma.com/

Twitter/X: ars_pharma

Top Investors: Deerfield, RA Capital Management, SR One

Description:

ARS Pharmaceuticals is a stealth pharmaceutical company that developed a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient, and more reliable for patients and loved ones at risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.

Total Funding Amount:

$75M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2015-01-01

Founders:

Richard Lowenthal, Sarina Tanimoto

Number of Employees:

11-50

Last Funding Date:

2021-08-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai